The Debate Over Aspirin Use for Stroke Prevention

According to a recent MedPage Today article, the U.S. Food and Drug Administration (FDA) released a message to consumers against the use of aspirin for primary prevention of stroke and heart attack, stating that evidence does not support its use, and citing risk factors. While the agency did add that for secondary prevention aspirin’s benefits do outweigh the risks, not everyone agrees with the FDA’s perspective, including the American Heart Association, whose guidelines indicate aspirin use for the primary prevention of stroke. A number of physicians provided their thoughts on the issue and how the statement will impact their practices. To read the full article, click here.